Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  alpha-1,3-galactosyltransferase-expressing allogeneic lung tumor cell vaccine
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-1 of 1 for your search:
Start Over
Phase I/II Study of Vaccination Comprising a-1,3-Galactosyltransferase-Expressing Allogeneic Tumor Cells (HyperAcute™ Lung Cancer Vaccine) in Patients With Advanced Refractory or Recurrent Non-Small Cell Lung Cancer (Phase I Is Closed to Accrual as of 10/06/09)
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: NCI-04-C-0049, NLGC-0101, NCT00075790
Start Over